Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 28 tags : Therapy save search
Global Immunotherapy Drugs Markets 2021-2026 - Launch of NG Immunotherapies / COVID-19 as Growth Catalyst / Approval of Novel Immunotherapy Drugs / Surge in Adoption of Car T-Cell Therapies
Published: 2021-10-28 (Crawled : 18:00) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
covid immunotherapy therapy drug growth approval t-cell car-t
XBiotech to Launch Novel Candidate Therapy for StrokeCompany Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After Stroke
Published: 2021-10-28 (Crawled : 18:00) - biospace.com/
XBIT | $8.11 -0.86% 53K
|
Health Technology
|
| O: 0.56%
H: 4.35%
C: 0.7%
new drug stroke test therapy biotech drug iot train
XBiotech to Launch Novel Candidate Therapy for Stroke
Published: 2021-10-28 (Crawled : 17:00) - globenewswire.com
XBIT | $8.11 -0.86% 53K
|
Health Technology
|
| O: 0.56%
H: 4.35%
C: 0.7%
stroke therapy biotech iot
MaxCyte Signs Strategic Platform License with Nkarta, Inc. to Advance Natural Killer Cell Therapy Programs
Published: 2021-10-28 (Crawled : 16:00) - biospace.com/
NKTX | $7.14 -5.56% 470K
|
Health Technology
|
| O: 1.03%
H: 1.98%
C: -1.44%
therapy license
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
Published: 2021-10-28 (Crawled : 14:15) - igmbio.com
IGMS | $8.11 5.33% 580K
|
Health Technology
|
| O: 0.37%
H: 3.74%
C: 3.25%
therapy cancer antibody
Candle Market to Grow by USD 3.40 Billion between 2020 and 2025 | Growing Adoption of Scented Candles for Home Décor and Aromatherapy to Boost the Market Growth | Technavio
Published: 2021-10-28 (Crawled : 12:00) - prnewswire.com
RBGPF | News | $52.06 4.8K
|
Consumer Non-Durables
|
| O: 2.1%
H: 0.96%
C: -0.3%
RBGLY | News | $10.59 850K
|
Manufacturing
|
| O: 1.94%
H: 0.92%
C: 0.55%
therapy growing growth
Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China
Published: 2021-10-28 (Crawled : 00:00) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
INCY | $51.45 -0.39% 720K
|
Health Technology
|
| O: 0.49%
H: 1.01%
C: 0.69%
treatment china therapy collaboration cancer vaccine
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.